David C. Griffith
Impact in
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
- Pharmacology 36
- Antibiotics Pharmacokinetics and Efficacy 35
-
- Antibiotic Resistance in Bacteria 34
- Co-authors
- Michael N. Dudley (32 shared papers)Olga Lomovskaya (6 shared papers)Mojgan Sabet (13 shared papers)Ziad Tarazi (12 shared papers)Debora Rubio-Aparicio (5 shared papers)Ruslan Tsivkovski (3 shared papers)Dongxu Sun (4 shared papers)Mark A. Miller (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (27 papers)Open Forum Infectious Diseases (8 papers)Journal of Adolescent Health (2 papers)Journal of Cystic Fibrosis (2 papers)Bioorganic & Medicinal Chemistry (2 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
David C. Griffith
60 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 113
- Molecular Medicine 1.0k
- Applied Microbiology and Biotechnology 249
- Endocrinology 245
- Pharmacology 783
- Infectious Diseases 291
Countries citing papers authored by David C. Griffith
This map shows the geographic impact of David C. Griffith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Griffith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Griffith more than expected).
Fields of papers citing papers by David C. Griffith
This network shows the impact of papers produced by David C. Griffith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Griffith. The network helps show where David C. Griffith may publish in the future.
Co-authors
The 25 scholars most cited alongside David C. Griffith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 278 | |
| 2 | 1997 | 167 | |
| 3 | 2006 | 160 | |
| 4 | 2020 | 158 | |
| 5 | 2015 | 96 | |
| 6 | 2018 | 66 | |
| 7 | 2016 | 63 | |
| 8 | 2011 | 63 | |
| 9 | 2009 | 52 | |
| 10 | 2018 | 46 | |
| 11 | 2009 | 45 | |
| 12 | 2017 | 41 | |
| 13 | 2010 | 40 | |
| 14 | 2008 | 38 | |
| 15 | 2017 | 36 | |
| 16 | 2018 | 36 | |
| 17 | 2020 | 35 | |
| 18 | 2009 | 35 | |
| 19 | 2021 | 34 | |
| 20 | 2020 | 31 |
About David C. Griffith
David C. Griffith is a scholar working on Pharmacology, Molecular Medicine, Epidemiology, Infectious Diseases and Molecular Biology, having authored 62 papers that have together received 2.0k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (35 papers), Antibiotic Resistance in Bacteria (34 papers), Cystic Fibrosis Research Advances (9 papers), HIV/AIDS Research and Interventions (9 papers), Pneumonia and Respiratory Infections (7 papers), Inhalation and Respiratory Drug Delivery (6 papers), Antibiotic Use and Resistance (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). The work is most often cited by research in Molecular Medicine (1.0k citations), Applied Microbiology and Biotechnology (249 citations), Endocrinology (245 citations), Pharmacology (783 citations) and Infectious Diseases (291 citations). David C. Griffith has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Michael N. Dudley, Olga Lomovskaya, Mojgan Sabet, Ziad Tarazi, Debora Rubio-Aparicio, Ruslan Tsivkovski, Dongxu Sun, Mark A. Miller, Louise A. Kelly‐Hope and Kirk Nelson. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Open Forum Infectious Diseases, Journal of Adolescent Health, Journal of Cystic Fibrosis and Bioorganic & Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.